More severe disability of North Africans vs Europeans with multiple sclerosis in France

Neurology

Volumn 68, Issue 1, 2007, Pages 29-32

  Debouverie, M ^a,c   Lebrun, C ^b   Jeannin, S ^b   Pittion Vouyovitch, S ^a   Roederer, T ^c   Vespignani, H ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c Marin Hospital   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISABILITY SEVERITY; DISEASE COURSE; EXPANDED DISABILITY STATUS SCALE; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; PRIORITY JOURNAL;

ADULT; AFRICA, NORTHERN; AFRICAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; DISABILITY EVALUATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 33846083715     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000250347.51674.d7     Document Type: Article

References (36)

1. Cabre P, Signate A, Olindo S, et al. Role of return migration in the emergence of multiple sclerosis in the French West Indies. Brain 2005;128:2899-2910.
2. Cree BA, Khan O, Bourdette D, et al. Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology 2004;63:2039-2045.
3. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol 2003;2:117-127.
4. Kurtzke JF. Epidemiologic contributions to multiple sclerosis: an overview. Neurology 1980;30:61-79.
5. Page WF, Mack TM, Kurtzke JF, Murphy FM, Norman JE Jr. Epidemiology of multiple sclerosis in US veterans. 6. Population ancestry and surname ethnicity as risk factors for multiple sclerosis. Neuroepidemiology 1995;14:286-296.
6. Sadovnick AD, Ebers GC. Epidemiology of multiple sclerosis: a critical overview. Can J Neurol Sci 1993;20:17-29.
7. Yamasaki K, Horiuchi I, Minohara M, et al. HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain 1999;122:1689-1696.
8. Delasnerie-Laupretre N, Alperovitch A. Migration and age at onset of multiple sclerosis: some pitfalls of migrant studies. Acta Neurol Scand 1992;85:408-411.
9. Kurtzke JF, Delasnerie-Laupretre N, Wallin MT. Multiple sclerosis in North African migrants to France. Acta Neurol Scand 1998;98:302-309.
10. Yaouang J. Incidence of multiple sclerosis in Western France, 2000-2001. Mult Scler 2006; 11(suppl 1). Abstract .
11. Dean G, Elian M. Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis. J Neurol Neurosurg Psychiatry 1997;63:565-568.
12. Gale CR, Martyn CN. Migrant studies in multiple sclerosis. Prog Neurobiol 1995;47:425-448.
13. Hammond SR, English DR, McLeod JG. The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia. Brain 2000;123:968-974.
14. Kurtzke JF, Bui QH. Multiple sclerosis in a migrant population: 2. Half-orientals immigrating in childhood. Ann Neurol 1980;8:256-260.
15. Delasnerie-Laupretre N, Alperovitch A. Childhood infections in multiple sclerosis: a study of North African-born patients who migrated to France. The French Collaborative Group on Multiple Sclerosis. Neuroepidemiology 1990;9:118-123.
16. Confavreux C, Compston DA, Hommes OR, McDonald WI, Thompson AJ. EDMUS, a European database for multiple sclerosis. J Neurol Neurosurg Psychiatry 1992;55:671-676.
17. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
18. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121-127.
19. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005;58:840-846.
20. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983;33:1444-1452.
21. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907-911.
22. Confavreux C, Vukusic S, Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003;126:770-782.
23. Ebers GC. Natural history of multiple sclerosis. J Neurol Neurosurg Psychiatry 2001; 71(suppl 2):ii16-ii19.
24. Weinshenker BG, Bass B, Rice GP, et al. The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain 1989;112:1419-1428.
25. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med 2000;343:1430-1438.
26. Weinshenker BG, Bass B, Rice GP, et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989;112:133-146.
27. Zhang SM, Willett WC, Hernan MA, Olek MJ, Ascherio A. Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women. Am J Epidemiol 2000;152:1056-1064.
28. Munger KL, Zhang SM, O'Reilly E, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004;62:60-65.
29. Hernan MA, Olek MJ, Ascherio A. Cigarette smoking and incidence of multiple sclerosis. Am J Epidemiol 2001;154:69-74.
30. Hernan MA, Jick SS, Logroscino G, Olek MJ, Ascherio A, Jick H. Cigarette smoking and the progression of multiple sclerosis. Brain 2005;128:1461-1465.
31. Alonso A, Jick SS, Olek MJ, Ascherio A, Jick H, Hernan MA. Recent use of oral contraceptives and the risk of multiple sclerosis. Arch Neurol 2005;62:1362-1365.
32. Shabas D, Heffner M. Multiple sclerosis management for low-income minorities. Mult Scler 2005;11:635-640.
33. Kaufman MD, Johnson SK, Moyer D, Bivens J, Norton HJ. Multiple sclerosis: severity and progression rate in African Americans compared with whites. Am J Phys Med Rehabil 2003;82:582-590.
34. Morariu MA, Linden M. Multiple sclerosis in American blacks. Acta Neurol Scand 1980;62:180-187.
35. Weinstock-Guttman B, Jacobs LD, Brownscheidle CM, et al. Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis Consortium. Mult Scler 2003;9:293-298.
36. Cree BA, Al Sabbagh A, Bennett R, Goodin D. Response to interferon beta-1a treatment in African American multiple sclerosis patients. Arch Neurol 2005;62:1681-1683.